Project Grant R01HL188933
Award Date 9/1/26
Completion Date 8/31/30
Dollars Obligated $754K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded the University of Alabama at Birmingham $1,491,464 under the Cardiovascular Diseases Research program (CFDA 93.837) on May 1, 2026, for Project Grant R01HL178770, a research study comparing ambulatory blood pressure monitoring (ABPM) to wrist-worn home blood pressure monitoring (HBPM) in assessing end-organ damage. The study, titled AW-COMPARE, will evaluate whether wrist-worn HBPM devices can replace ABPM as the reference standard for...
- Federal Grant Award Summary The University of Alabama at Birmingham received a $222,750 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded July 21, 2025, with a completion date of June 30, 2027. The grant supports the development of a clinical decision support questionnaire designed to identify barriers to blood pressure control among adults with hypertension. This tool addresses a critical gap in...
- The National Heart Lung and Blood Institute awarded the University of Pittsburgh $1,019,556 on July 13, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a randomized clinical trial testing an adaptive mobile health blood pressure intervention for hypertension management in limited-resource primary care settings. The trial, titled "The Hypertension Toolkit: An Adaptive Mobile Health Blood Pressure Intervention," enrolls 378 participants across...
- The National Heart, Lung, and Blood Institute awarded the University of Alabama at Birmingham $734,986 on August 4, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct genetic architecture research on natriuretic peptides and their role in blood pressure regulation. The research leverages whole genome sequencing data from multiethnic cohorts—including the Transomics for Precision Medicine cohorts, UK Biobank, and All of Us Research Program—to identify common,...
- The National Heart, Lung, and Blood Institute awarded the University of Mississippi Medical Center $333,250 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to adapt and pilot-test a home blood pressure monitoring intervention for rural Mississippi. The recipient will modify a validated chronic disease self-management program that combines longitudinal home blood pressure monitoring with a smartphone-delivered virtual agent providing personalized education. The...
- The National Heart, Lung, and Blood Institute awarded the University of Alabama at Birmingham $713,515 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 1, 2026, to investigate the neural mechanisms linking meal timing, circadian rhythms, and blood pressure control in diet-induced obesity. The project, titled "Food Intake Timing on Circadian Control of Blood Pressure in Diet-Induced Obesity," seeks to elucidate how the suprachiasmatic nucleus and...
- Federal Project Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Alabama at Birmingham $223,438 on September 4, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a clinical research study examining hypertension incidence in people with HIV initiating antiretroviral therapy (ART). The project, scheduled for completion by August 31, 2027, will assess blood pressure outcomes in ART-naïve individuals starting either...
- The National Heart, Lung, and Blood Institute awarded Brigham & Women's Hospital Inc. $908,994 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to test implementation strategies for electronic health record-based interventions to improve hypertension control in primary care settings. The project builds on the recipient's prior NIH-funded REDUCE-BP trial, which enrolled 49,210 patients and 560 primary care providers and demonstrated that multi-component...
- <p>The National Institutes of Health National Heart Lung and Blood Institute awarded the University of Alabama at Birmingham $223,500 on June 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to adapt telecommunicator CPR instructions to enhance layperson response to pediatric cardiac arrest. The award is a Project Grant (R03HL185261) with a period of performance through May 31, 2028, and work is performed in Birmingham, Alabama.</p>
- The National Heart, Lung, and Blood Institute awarded the University of Alabama at Birmingham $735,327 on June 22, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to examine individual and contextual risk factors for chronic limb-threatening ischemia (CLTI) and contributors to racial and geographic disparities in CLTI outcomes. The award funds research leveraging the REGARDS (Reasons for Geographic and Racial Differences in Stroke) study, a longitudinal cohort of...